Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous uric acid pharmacokinetics in acute ischemic stroke (<12 hours)
2004-002937-37Phase 2Active
- Sponsor
- Hospital Clínic de Barcelona
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Uric acid in ischemic stroke, sponsored by Hospital Clínic de Barcelona. Primary endpoints: Serum uric acid concentrations over time and Clinical safety of intravenous uric acid. Started Apr 2005; status: active.
02
Drugs
Uric acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2004-002937-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002937-37.